Search

Author/Creator Thin, L

2. P399 Higher anti-tumour necrosis factor-alpha drug levels are associated with improved radiological outcomes in patients with perianal fistulising Crohn's disease: A retrospective multi-centre study. (27th May 2021)

Authors:
De Gregorio, M; Lee, T; Krishnaprasad, K; Amos, G; An, Y K; Bastian-Jordan, M; Begun, J; Borok, N; Brown, D J M; Cheung, W; Connor, S; Gerstenmaier, J; Gilbert, L E; Gilmore, R; Gu, B; Kutaiba, N; Lee, A; Mahy, G; Srinivasan, A; Thin, L
Journal:
Journal of Crohn's and colitis
Issue:
Volume 15(2021)Supplement 1
Page Start:
S408
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P523 Endoscopic balloon dilatation is safe and has a high success rate in patients with stricturing Crohn's disease. (25th January 2019)

Authors:
Lim, E; Thai, M; Hendy, P; Alchlaihawi, M; Leong, R; Connor, S; Ng, W; Gu, B; van Langenberg, D; Thin, L; Schulberg, J; Kamm, M; Gilmore, R; Taylor, K; Sallis, O; Andrews, J; Daker, C; Barclay, M; Wark, G; Ghaly, S
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S374
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. P571 Vedolizumab (VDZ) real-world outcomes in ulcerative colitis (UC). (16th January 2018)

Authors:
Pulusu, S S R; Srinivasan, A; Krishnaprasad, K; Cheng, D; Mogilevski, T; Flanagan, E; Keung, C; Wu, C; Prosser, R; Sawyer, E; Rizvi, Q -U -A; Su, H; Leung, W -K; Edmundson, A; Cooke, S; Mahy, G; Thin, L; Radford-Smith, G; Sparrow, M; Andrews, J M
Journal:
Journal of Crohn's and colitis
Issue:
Volume 12:Number 1(2018:Jan.)Supplement 1
Page Start:
S395
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. P614 Reduction of bowel wall thickness and doppler signals as early as 36 hours predicts corticosteroid response in a multi-centre prospective cohort of Acute Severe Ulcerative Colitis: USUC Study including the GENIUS cohort. (30th January 2023)

Authors:
An, Y K; Fernandes, R; Lindsay, N; Khoo, E; Pham, H; Wong, K F; Thin, L; Goodsall, T; Bryant, R V; Wright, E; Smith, R; Friedman, A; Begun, J
Journal:
Journal of Crohn's and colitis
Issue:
Volume 17(2023)Supplement 1
Page Start:
i743
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. P663 Post-ustekinumab induction IL12, IL23, and ustekinumab levels are associated with clinical response in a multi-centre prospective cohort study of Crohn's disease patients: results from the AURORA Study including ANZIBDC Cohort. (30th January 2023)

Authors:
An, Y K; Lindsay, N; Allan, N; Khoo, E; Fernandes, R; Amiss, A; Pham, H; Wong, K F; Ooi, S Y; Thin, L; Lightowler, D; Connor, S J; Williams, A J; De Cruz, P; Li Wai Suen, C; Kariyawasam, V; Mitrev, N; Ghaly, S; Andrews, J M; Christensen, B
Journal:
Journal of Crohn's and colitis
Issue:
Volume 17(2023)Supplement 1
Page Start:
i793
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. P753 Comparing long-term outcomes in inflammatory bowel disease patients between switch and non-switch cohorts: no differences in infliximab persistence or safety outcomes after 54 months. (30th January 2023)

Authors:
Suo, P; Thin, L; Srinivasan, A; Winston, J; Jeffrey, A; Menon, S; Ghaly, S; Haifer, C
Journal:
Journal of Crohn's and colitis
Issue:
Volume 17(2023)Supplement 1
Page Start:
i884
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗